Prevalence of Hearing Loss and Hearing Aid Use Among Adults in France in the CONSTANCES Study

Lisan, Q.; Goldberg, Marcel; Lahlou, Ghizlène; Ozguler, Anna; Lemonnier, Sylvie; Jouven, Xavier; Zins, Marie; Empana, Jean‐Philippe

doi:10.1001/jamanetworkopen.2022.17633

Cited by 19 publications

(12 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…But, there are both similarities and differences to the latest nationally-representative prevalence data in comparable countries. For instance, for the "CONSTANCES" study in France, which were collected between 2011 and 2019, the prevalence-by-age curve for males closely matches those that from the NSH, but for females, the French values are almost 10% greater than the NSH's for 50's and 60's(Lisan et al, 2022). The resulting uncertainty as to which way the prevalence of hearing loss in the UK has actually changed since the 1980s emphasises the paucity of current epidemiological data(Whitty, 2023) and indicates that a suitable new UK national study of hearing needs be considered.…”

mentioning

confidence: 89%

Population estimates of the number of adults in the United Kingdom with a hearing loss updated using 2021 and 2022 census data

Akeroyd,

Munro

2024

Preprint

View full text Add to dashboard Cite

We update an earlier publication (Akeroyd MA et al., Int J Audiol. 2014) to derive new estimates of the number of adults in the UK with a hearing loss, using population data from the 2021/2022 UK censuses and prevalence data from the UK National Study of Hearing (Akeroyd MA et al. Trends In Hearing 2019). Setting a criterion of a four-frequency hearing level >= 35 dB in the better ear gives an estimate of 4.6 million adults aged 18 to 80, which is a 17% increase on the earlier value from the 2011 census. With a criterion of >= 20 dB hearing level, the estimate is 12.3 million in total, or 1 in 4 of the population aged 18-80. The revised numbers highlight just how common hearing problems are in the population.

show abstract

mentioning

confidence: 89%

Population estimates of the number of adults in the United Kingdom with a hearing loss updated using 2021 and 2022 census data

Akeroyd,

Munro

2024

Preprint

View full text Add to dashboard Cite

show abstract

“…Germany has a prevalence of 16-25% in systematic literature searches 8 . A cohort study in France estimated the prevalence among 18-to 75-year-olds to be 25% 9 . In India, metaanalyses reported a prevalence of hearing loss ranging from 6 to 26.9% 10 .…”

Section: Introductionmentioning

confidence: 99%

Clinical characteristics of the “Gap” between the prevalence and incidence of hearing loss using National Health Insurance Service data

Lee,

Yoon,

Lee

et al. 2023

Preprint

View full text Add to dashboard Cite

Hearing loss is the inability to hear speech or sounds well, owing to a number of causes. This study aimed to simultaneously determine the prevalence, incidence, and the gap between them in hearing loss in South Korean patients at the same point in time as well as to identify patients who have not recovered from hearing loss. We examined the prevalence and incidence of patients diagnosed with hearing loss in the National Health Insurance Service database over an 11-year period from 2010 to 2020. The difference between prevalence and incidence was defined by the term “Gap”. Clinical characteristics such as sex and age per 100,000 individuals were examined. As of 2020, the domestic prevalence and incidence rates obtained in this study were 1.84% and 1.57%, respectively, and the prevalence and incidence rates increased with increasing age. The gap was 0.27%, which showed a steady increasing trend from 2011 to 2020, and the total medical expenses increased accordingly. Because hearing loss is an irreversible disease, this Gap could mean many things, but it could be seen as a patient who has never recovered from hearing loss.

show abstract

“…Chien and Lin [ 9 ] estimated that one in seven Americans over the age of 50 who have hearing loss use hearing aids. In a recent large cohort study of French adults, only 37% of people with hearing loss reported using hearing aids [ 10 ]. In Belgium, 38% of adults aged 80 and over with moderate hearing loss are underserved in the hearing care [ 11 ].…”

Section: Introductionmentioning

confidence: 99%

Interindividual variability in the benefits of personal sound amplification products on speech perception in noise: A randomized cross-over clinical trial

2023

View full text Add to dashboard Cite

Objective The aging population is prone to hearing loss, which has several adverse effects on quality of life, including difficulty following conversations in noisy environments. Personal Sound Amplification Products (PSAPs) are a less expensive, over-the-counter alternative to traditional, more expensive hearing aids. Although some studies have shown that PSAPs can mitigate hearing loss, the literature generally only addresses group differences without considering interindividual variability. This study aimed to 1) determine how PSAPs affect listening effort and speech perception in noise and 2) measure interindividual variability and identify contributing demographic and health factors. Design We used a cross-over design in which all participants were assigned to each condition. Participants Twenty-eight adults aged 60 to 87 years with normal hearing and mild hearing loss fulfilled the study requirements. Intervention In one session, speech-in-noise perception tasks were performed without PSAPs, and in the other, the tasks were performed with bilateral PSAPs. The two sessions were separated by one week, and the order of the sessions was balanced across participants. Main outcome measures In both sessions, participants performed the Quick speech-in-noise test and a word discrimination task in noise, in which their self-reported listening effort was measured. Results PSAPs use improved speech perception in noise in both tasks and reduced listening effort. There was considerable variability between individuals, with approximately 60–70% of participants showing benefit. Age, hearing and cognitive status were significant predictors of the benefits. Conclusion Not all individuals may benefit from the effect of PSAPs to the same extent at their first use, and this depends on specific health and demographic factors, particularly age, hearing, and cognitive status. These results underscore the importance of demographic and health factors in assessing the benefits of hearing amplification in older adults. Trial registration ClinicalTrials.gov, NCT05076045.

show abstract

Prevalence of Hearing Loss and Hearing Aid Use Among Adults in France in the CONSTANCES Study

Cited by 19 publications

References 43 publications

Population estimates of the number of adults in the United Kingdom with a hearing loss updated using 2021 and 2022 census data

Population estimates of the number of adults in the United Kingdom with a hearing loss updated using 2021 and 2022 census data

Clinical characteristics of the “Gap” between the prevalence and incidence of hearing loss using National Health Insurance Service data

Interindividual variability in the benefits of personal sound amplification products on speech perception in noise: A randomized cross-over clinical trial

Contact Info

Product

Resources

About